Hydroxyapatite is the natural mineral of teeth and bone, used in fluoride-free toothpaste and bone-targeted calcium. Strongest evidence: easing tooth sensitivity and rebuilding early enamel damage; it also lowers new cavities comparably to fluoride. A bone-derived form slightly slows bone loss, mainly in women past menopause. Very well tolerated; main caution is total calcium intake. (Full Review)

Protocol

Oral Care

Toothpaste twice daily

Nano-hydroxyapatite ~10% (up to ~29.5%); mirrors normal fluoride-toothpaste use

Bone Support

~1,000+ mg elemental calcium/day

Ossein-hydroxyapatite complex, often split, in postmenopausal or osteopenic individuals

Timing

Brush morning and night

Especially before bed; supplement split into ≤500 mg doses with food

Time to effect

Sensitivity Relief

2–4 weeks

Often noticeable with twice-daily use

Enamel & Caries

Months

Remineralization of early lesions and caries-prevention benefits accrue

Bone Density

6–12 months+

Changes from the supplement form take this long to measure

Benefits

High: Reduction of dentin hypersensitivity; remineralization of early enamel lesions

Medium: Caries prevention; preservation of bone mineral density

Low: Prevention of white spot lesions during orthodontic treatment; improvement of pain and quality of life in osteopenia

Speculative: Systemic longevity or healthy-aging effects; gut or microbiome benefits from swallowed hydroxyapatite

Contraindications

Supplement form: hypercalcemia

Supplement form: severe chronic kidney disease (eGFR <30)

Supplement form: primary hyperparathyroidism

Supplement form: active calcium-stone disease

Key Interactions

Thyroid hormone (levothyroxine)

Tetracycline and fluoroquinolone antibiotics (doxycycline, ciprofloxacin)

Bisphosphonates (alendronate, risedronate)

Iron supplements

Calcium-containing antacids and other calcium sources

High-dose vitamin D

Risk & Side Effects

Low: Excess calcium intake from the bone-derived complex; mild local or gastrointestinal effects

Speculative: Theoretical nanoparticle concerns; overreliance displacing proven fluoride in high-risk individuals

Monitoring

Marker	Target	Why
Serum calcium	9.2–10.0 mg/dL	Detects hypercalcemia from excess intake
25-hydroxyvitamin D	40–60 ng/mL	Governs how supplemental calcium is absorbed and handled
Parathyroid hormone (PTH)	15–40 pg/mL	Reflects calcium regulation; flags hyper/hypoparathyroidism
eGFR	>90 mL/min/1.73m²	Confirms kidneys can handle a higher calcium load
Bone mineral density (DXA T-score)	Above −1.0	Tracks the skeletal benefit over time

Cadence: Baseline before starting (supplement form); recheck calcium-related markers ~3 months after a dose change, then every 6–12 months; DXA every 1–2 years. No testing required for topical oral-care use.

Qualitative Assessment

Tooth sensitivity to cold, air, and sweets (reduced over weeks)
Comfort during dental cleanings and with temperature changes
Dentist-observed reduction or stabilization of early white-spot lesions
For the supplement: absence of new fractures and overall musculoskeletal comfort

Hydroxyapatite for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment